Every cancer is different. Grouping cancer mutations by their structure and function could help make treatments more personalized.
Academic rigor, journalistic flair
Articles on Personalized medicine
Displaying all articles
Medical education has not kept up with genetic discoveries — primary care physicians require more genetics and genomics training.
Our bodies have a set of defenses that are finely tuned for killing invading microbes. With rising cases of drug-resistant bacteria, maybe boosting our natural defenses is the best medicine.
Male and female tumors are different. Researchers are now hoping to exploit these sex-specific differences to treat brain cancer. This might improve survival for everyone.
Small-batch brewers are starting to tinker with biologic drugs to meet their own medical needs. A side effect of their success would be a disruption to how big pharma makes and distributes drugs.
African-Americans are severely underrepresented in genetics and neuroscience research. That could leave the treatments of the future out of their reach.
A field called epigenomics looks at chemical modifications that do not change our DNA sequence but can affect gene activity. What are the limitations, and can biomedicine use this to our advantage?
Top contributors
-
Assistant Professor of Systems Biology and Cancer Metabolism, University of California, Merced
-
Director of the Lieber Institute for Brain Development and Professor, Departments of Psychiatry, Neurology, Neuroscience and The Institute of Genetic Medicine, Johns Hopkins University
-
Professor, Abell Chair in Synthetic Biology, Colorado State University
-
Postdoctoral Researcher in Chemical and Biological Engineering, Colorado State University
-
Professor of Biology, McMaster University
-
Postdoctoral Fellow, University of Pennsylvania
-
Professor, Pediatrics and Neuroscience, Washington University in St Louis
-
Assistant Professor of Thoracic & Head and Neck Oncology, The University of Texas MD Anderson Cancer Center
